These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7495962)

  • 1. Hepatitis A virus and blood products: virus validation studies.
    Lemon SM
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S20-2. PubMed ID: 7495962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates.
    Hamman J; Zou J; Horowitz B
    Vox Sang; 1994; 67 Suppl 1():72-6; discussion 77. PubMed ID: 8091742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate.
    Lemon SM; Murphy PC; Smith A; Zou J; Hammon J; Robinson S; Horowitz B
    J Med Virol; 1994 May; 43(1):44-9. PubMed ID: 8083647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus validation experiments on the production process of OCTAVI SDPlus.
    Biesert L; Lemon S; Suhartono H; Wang L; Rübsamen H
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S48-54. PubMed ID: 7495968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
    Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products.
    Lemon SM
    Vox Sang; 1994; 67 Suppl 4():19-23; discussion 24-6. PubMed ID: 7831865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A virus and polymerase chain reaction amplification: methodology and results.
    Robertson BH; Normann A; Graff J; Flehmig B; Friedberg D; Shouval D
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S27-31. PubMed ID: 7495964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate.
    Arrighi S; Rossi R; Borri MG; Lesnikov V; Lesnikova M; Franco E; Divizia M; De Santis ME; Bucci E
    Thromb Haemost; 1995 Sep; 74(3):868-73. PubMed ID: 8571312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A virus infections associated with clotting factor concentrate in the United States.
    Soucie JM; Robertson BH; Bell BP; McCaustland KA; Evatt BL
    Transfusion; 1998 Jun; 38(6):573-9. PubMed ID: 9661691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool.
    Chudy M; Budek I; Keller-Stanislawski B; McCaustland KA; Neidhold S; Robertson BH; Nübling CM; Seitz R; Löwer J
    J Med Virol; 1999 Feb; 57(2):91-9. PubMed ID: 9892390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and biochemical characterization of a double-virus-inactivated factor VIII preparation.
    Robinson S; Schwinn H; Josic D; Nur I; Stadler M; Bal F; Gehringer W; Schütz R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S40-7. PubMed ID: 7495967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of hepatitis A virus by heat treatment in aqueous solution.
    Murphy P; Nowak T; Lemon SM; Hilfenhaus J
    J Med Virol; 1993 Sep; 41(1):61-4. PubMed ID: 8228940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 15. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
    Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU; Purcell RH
    Ann Intern Med; 1994 Jan; 120(1):1-7. PubMed ID: 7504424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal and inactivation of hepatitis B virus from contaminated pooled plasma in a large-scale manufacturing process for factor VIII and human serum albumin.
    Murozuka T; Aoki M; Kimura N; Sotoyama K; Abe I; Izumi H; Emura H; Takeda Y; Nanakawa H; Katsubayashi Y; Takeuchi T; Ito H; Hirakawa S; Mitsunaga S; Tadokoro K; Kanemitsu K; Miyamoto M; Yamanaka R; Nishioka K
    Vox Sang; 1999; 76(3):181-6. PubMed ID: 10341335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-binding activity of fibronectin: masking of hepatitis A virus.
    Seelig R; Pott G; Seelig HP; Liehr H; Metzger P; Waldherr R
    J Virol Methods; 1984 Jul; 8(4):335-47. PubMed ID: 6088567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hepatitis A virus transmission by high-purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacs.
    Watson HG; Ludlam CA; McOmish F; Dennis R; Hart H; Simmonds P
    Br J Haematol; 1995 Jan; 89(1):214-6. PubMed ID: 7833268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of hepatitis A by transfusion of blood products.
    Sherertz RJ; Russell BA; Reuman PD
    Arch Intern Med; 1984 Aug; 144(8):1579-80. PubMed ID: 6087755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the hepatitis A epidemics in hemophiliacs in Europe.
    Vermylen J; Peerlinck K
    Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.